PATENT CLAIM ANALYSIS

Application Number: 15913466
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "180000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.

Claim (Index 9):
The method of  claim 1 , wherein the lipid cake mixture further comprises cholesterol.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.5873
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14377211', '13816640', '12919807', '12142083', '15043750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7436742954984117
- 35 USC 102 Novelty (BERT): 0.4847283290357499
- Combined Prediction Score: 0.7177796988521455
- Mean Citation Score: 167.784882
- Max Citation Score: 253.81787000000003
- Similarity Product: 238.2478562712604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test